for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-Prometic Receives Rare Pediatric Disease Designation From U.S. FDA For Its Inter-Alpha-Inhibitor-Proteins

March 5 (Reuters) - Prometic Life Sciences Inc:

* PROMETIC RECEIVES RARE PEDIATRIC DISEASE DESIGNATION FROM U.S. FDA FOR ITS INTER-ALPHA-INHIBITOR-PROTEINS

* PROMETIC LIFE SCIENCES INC - IN ADDITION TO RARE PEDIATRIC DISEASE DESIGNATION, IAIP HAS ALSO BEEN GRANTED AN ORPHAN DRUG DESIGNATION BY FDA

* PROMETIC LIFE SCIENCES - COSTS ASSOCIATED WITH CLINICAL PROGRAM RELATED TO THE PEDIATRIC & ORPHAN DRUG DESIGNATIONS “WILL NOT IMPACT OUR FY2018 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up